title: Quantitative and qualitative changes of extracellular-superoxide dismutase in patients with various diseases.
abstract: Extracellular-superoxide dismutase (EC-SOD) is a secretory glycoprotein that is the major SOD isozyme in extracellular fluids. It has previously been shown that EC-SOD levels in sera from healthy persons are clearly divided into two discontinuous groups: a lower group (named Group I, below 120 ng/ml) and a higher group (Group II, above 400 ng/ml). The family studies have shown that the high EC-SOD level in healthy persons is genetically transmitted. We report here on the EC-SOD levels in the sera of patients with various diseases. The EC-SOD levels were distinctly higher in patients with renal diseases and moderately higher in liver diseases and diabetes than those in normal healthy persons. In cerebrovascular diseases, heart diseases and acute digestive diseases, significant differences of EC-SOD were not observed. In patients with renal diseases, the increase of EC-SOD was accompanied by the lack of renal function. Serum EC-SOD in Group I healthy persons is known to be heterogeneous with regard to heparin affinity and can be separated into three fractions: A without affinity, B with weak affinity and C with relatively strong heparin affinity, whereas the EC-SOD in Group II is mainly one fraction of C-type. Also in the case of hemodialysis patients, serum EC-SOD in Group I or Group I' (approximately 120-400 ng/ml) was divided into three fractions. EC-SOD in Group II showed two different profiles on heparin-Sepharose column chromatographies: one consisted mainly of EC-SOD C and the other consisted of EC-SOD A and C. It is probable that the high serum EC-SOD level in hemodialysis patients was due to two possible factors: the genetic transmitted factor and unknown pathophysiological factor(s).
authors.affiliation: Department of Pharmaceutics, Gifu Pharmaceutical University, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Adachi
authors.forename: M
authors.initials: M
authors.lastname: Nakamura
authors.forename: H
authors.initials: H
authors.lastname: Yamada
authors.forename: A
authors.initials: A
authors.lastname: Futenma
authors.forename: K
authors.initials: K
authors.lastname: kato
authors.forename: K
authors.initials: K
authors.lastname: Hirano
mesh_terms: D002561:Cerebrovascular Disorders / Q000201:enzymology; D002846:Chromatography, Affinity; D003920:Diabetes Mellitus / Q000201:enzymology*; D004066:Digestive System Diseases / Q000201:enzymology; D005110:Extracellular Space / Q000201:enzymology*; D006331:Heart Diseases / Q000201:enzymology; D006493:Heparin / Q000378:metabolism; D006801:Humans; D007674:Kidney Diseases / Q000201:enzymology* / Q000628:therapy; D007676:Kidney Failure, Chronic / Q000201:enzymology; D008107:Liver Diseases / Q000201:enzymology*; D012016:Reference Values; D006435:Renal Dialysis; D013482:Superoxide Dismutase / Q000097:blood* / Q000235:genetics / Q000652:urine
chemical_list: D006493:Heparin; D013482:Superoxide Dismutase